ALLERGAN AUSTRALIA PTY LIMITED

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches

First Posted Date
2005-09-15
Last Posted Date
2013-11-18
Lead Sponsor
Allergan
Target Recruit Count
705
Registration Number
NCT00168428

A Research Study for Patients With Overactive Bladder

First Posted Date
2005-09-15
Last Posted Date
2013-11-06
Lead Sponsor
Allergan
Target Recruit Count
313
Registration Number
NCT00168454

A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia

Phase 2
Completed
Conditions
First Posted Date
2005-09-15
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
117
Registration Number
NCT00168441

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Phase 3
Completed
Conditions
First Posted Date
2005-09-15
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
193
Registration Number
NCT00168402

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

First Posted Date
2005-09-15
Last Posted Date
2019-04-23
Lead Sponsor
Allergan
Target Recruit Count
599
Registration Number
NCT00168324

A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema

Phase 3
Completed
Conditions
Interventions
First Posted Date
2005-09-15
Last Posted Date
2014-08-04
Lead Sponsor
Allergan
Target Recruit Count
554
Registration Number
NCT00168337

Memantine in Patients With Chronic Glaucoma

Phase 3
Completed
Conditions
First Posted Date
2005-09-15
Last Posted Date
2010-11-04
Lead Sponsor
Allergan
Target Recruit Count
1179
Registration Number
NCT00168350

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

First Posted Date
2005-09-15
Last Posted Date
2019-04-23
Lead Sponsor
Allergan
Target Recruit Count
668
Registration Number
NCT00168298

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Phase 4
Completed
Conditions
Interventions
First Posted Date
2005-09-15
Last Posted Date
2008-09-29
Lead Sponsor
Allergan
Target Recruit Count
424
Registration Number
NCT00168480

A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis

Phase 4
Completed
Conditions
Interventions
First Posted Date
2005-09-15
Last Posted Date
2008-09-29
Lead Sponsor
Allergan
Target Recruit Count
144
Registration Number
NCT00168415
© Copyright 2024. All Rights Reserved by MedPath